Drug Immune

Bafiertam

Payments companies reported to CMS as associated with Bafiertam. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$212Kassociated payments (2023-2025)
2,018clinicians with associated payments
2companies reporting

By year

2023 $107K
2024 $77K
2025 $28K

Payments reported as associated with Bafiertam, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $144K
Family $20K
Clinical Neurophysiology $12K
Nurse Practitioner $6,799
Physician Assistant $6,203
Adult Health (Nurse Practitioner) $3,666

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Bafiertam

These are the largest totals companies reported as associated with Bafiertam. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Rebecca Jones Phoenix, AZ Neurology (Psychiatry & Neurology) $14,585.71
Mary Ann Picone Teaneck, NJ Neurology (Psychiatry & Neurology) $12,962.68
Sangjin Oh Glen Burnie, MD Neurology (Psychiatry & Neurology) $12,291.45
Ajo Joy Gilbert, AZ Clinical Neurophysiology $11,057.91
Allan Perel Staten Island, NY Neurology (Psychiatry & Neurology) $5,467.89
Nida Laurin Scottsdale, AZ Neurology (Psychiatry & Neurology) $5,456.49
William Conte Merrillville, IN Neurology (Psychiatry & Neurology) $4,437.70
Lori Travis Phoenix, AZ Neurology (Psychiatry & Neurology) $3,983.13
Regina Berkovich West Hollywood, CA Neurology (Psychiatry & Neurology) $3,912.57
Ahmed Obeidat Milwaukee, WI Neurology (Psychiatry & Neurology) $2,643.00

Prescribed Bafiertam?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.